JSH BIOTECH ApS: Financial statements 2022
CVR: 25220129
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JSH BIOTECH ApS (CVR 25220129) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 340,943 and a net result of DKK -3,254,998 compared with DKK 3,090,356 the year before. That is a decrease of 47.5% compared with the year before. Equity in the 2022 report amounted to DKK 3,781,227. The solvency ratio was 48.2%.
- Gross Profit
- DKK 340,943
- Profit/Loss
- DKK -3,254,998
- Equity
- DKK 3,781,227
- Total Assets
- DKK 7,851,477
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 341 t. | -3.3 mio. | 3.8 mio. | - |
| 2021 | - | 649 t. | 3.1 mio. | 7.2 mio. | - |
| 2020 | - | 578 t. | 3.2 mio. | 4.2 mio. | - |
| 2019 | - | 266 t. | 438 t. | 992 t. | - |
| 2018 | - | -14 t. | 34 t. | 554 t. | - |
Official annual report
Keep an eye on JSH BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
JSH BIOTECH ApS has published its annual report for 2021. Gross profit came to DKK 648,973, and the net result was DKK 3,090,356.
About JSH BIOTECH ApS
JSH BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named VICH 5941 ApS. The management consists of John Sørensen Haurum. The company is owned by John Sørensen Haurum. In 2025, the company reported a gross profit of DKK 620,332 and a net result of DKK 3,409,861 compared with DKK 1,154,367 the year before. Equity in the 2025 report amounted to DKK 6,651,503.